These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 19769083)

  • 1. [Resistance screening].
    Sierra S; Lengauer T; Kaiser R
    MMW Fortschr Med; 2009 Apr; 151(18):72, 74-5. PubMed ID: 19769083
    [No Abstract]   [Full Text] [Related]  

  • 2. [Integrase inhibition].
    Bogner JR
    MMW Fortschr Med; 2009 Apr; 151(18):68-71. PubMed ID: 19769082
    [No Abstract]   [Full Text] [Related]  

  • 3. Study of different systems for interpreting results of genotypic antiretroviral drug resistance tests.
    García F; Palomares JC; Martínez NM; Alvarez M; Suarez S; García F; Rodríguez JM; Quero JH; del Carmen Maroto M
    Antivir Ther; 2003 Jun; 8(3):251-2. PubMed ID: 12924543
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy of advanced stages. "Mega-HAART" or "drug holiday"?].
    MMW Fortschr Med; 2000 Mar; 142 Suppl 1():86-7. PubMed ID: 10863323
    [No Abstract]   [Full Text] [Related]  

  • 5. Resistance testing grows more prevalent in U.S.
    AIDS Alert; 1998 Sep; 13(9):103-4. PubMed ID: 11365787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of serum levels of antiretroviral drugs].
    Kurowski M
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():62-4. PubMed ID: 15373053
    [No Abstract]   [Full Text] [Related]  

  • 7. Resistance test welcomed, with caution.
    AIDS Alert; 1997 Oct; 12(10):113-5. PubMed ID: 11364716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [How HIV treatment can be simplified. "Once daily" as starter therapy is effective].
    Wepner U
    MMW Fortschr Med; 2009 Apr; 151(18):80-1. PubMed ID: 19769085
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antiretroviral therapy. Simpler and more tolerable with equally high effectiveness].
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():78-9. PubMed ID: 16385885
    [No Abstract]   [Full Text] [Related]  

  • 10. [Reactions to the New York "supervirus". A challenge in primary resistance].
    Paukstadt W
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():86. PubMed ID: 16385890
    [No Abstract]   [Full Text] [Related]  

  • 11. Incorporating drug-resistance measurements into the clinical management of HIV-1 infection.
    Zolopa AR
    J Infect Dis; 2006 Sep; 194 Suppl 1():S59-64. PubMed ID: 16921474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and significance of minority quasispecies of drug-resistant HIV-1.
    Metzner KJ
    J HIV Ther; 2006 Dec; 11(4):74-81. PubMed ID: 17578210
    [No Abstract]   [Full Text] [Related]  

  • 13. A comparison of three computational modelling methods for the prediction of virological response to combination HIV therapy.
    Wang D; Larder B; Revell A; Montaner J; Harrigan R; De Wolf F; Lange J; Wegner S; Ruiz L; Pérez-Elías MJ; Emery S; Gatell J; D'Arminio Monforte A; Torti C; Zazzi M; Lane C
    Artif Intell Med; 2009 Sep; 47(1):63-74. PubMed ID: 19524413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [HIV eradication--facts and fiction].
    Jaeger H; Wolf E
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():72-3. PubMed ID: 19024923
    [No Abstract]   [Full Text] [Related]  

  • 15. [Resistance to antiretroviral drugs].
    Tamalet C; Yahi N; Koch N
    Med Trop (Mars); 1997; 57(2):121-6. PubMed ID: 9304001
    [No Abstract]   [Full Text] [Related]  

  • 16. Will drug resistance testing prove reliable enough to enhance HIV treatments?
    Murphy MJ
    Fac Notes (New Orleans La); 1998; 10(6):1-3. PubMed ID: 11366139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Viroseq-HIV version 2 for HIV drug resistance.
    Mukaide M; Sugiura W; Matuda M; Usuku S; Noguchi Y; Suzuki K; Kawata K; Ito A; Sagara H; Yamada K; Kondo M; Imai M
    Jpn J Infect Dis; 2000 Oct; 53(5):203-5. PubMed ID: 11135705
    [No Abstract]   [Full Text] [Related]  

  • 18. Selected topics from the 8th Conference on Retroviruses and Opportunistic Infections. February 4-8, 2001. Chicago, Illinois.
    Kuritzkes DR
    HIV Clin Trials; 2001; 2(3):219-26. PubMed ID: 11590531
    [No Abstract]   [Full Text] [Related]  

  • 19. Putting resistance to the test.
    Daar ES
    Posit Living; 2001 Apr; 10(3):15-6, 43-6. PubMed ID: 11548369
    [No Abstract]   [Full Text] [Related]  

  • 20. Multidrug-resistant HIV-1.
    Tayloe D
    Clin Infect Dis; 2004 May; 38(10):1507; author reply 1507. PubMed ID: 15156500
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.